Lifestyle
Harvard Professor Releases Book on Navigating Disagreement
Julia Minson's 'How to Disagree Better' offers evidence-based techniques to transform conflicts into opportunities for growth.
Cambridge Library Zoom Group Reshapes Elder Life on Mondays
A mindfulness and meditation group helps elders build community and cope with aging, illness, and grief.
Eastern Edge Food Hall opens in Kendall Square
New 11,000 sq ft food hall features 9 local vendors and seating for 275 guests
Crime
Worker seriously injured after bucket truck tips over on Memorial Drive
Accident shuts down part of Cambridge parkway for several hours
Fed Bans Ex-Employees of Two Banks for Misconduct
Regulators take action against former workers for embezzlement and misappropriation of funds.
LAPD & Flock: License Plate Readers Raise Privacy Concerns in LA
Automated license plate readers are expanding, but critics warn of potential abuses and erosion of civil liberties.
Business
Relay Therapeutics Outperforms ReNeuron Group in Biotech Comparison
Analysts see more potential upside for Relay Therapeutics based on stronger consensus rating and fundamentals.
MIT Trims Stake in Carvana, Still Its 2nd Largest Holding
The university's investment fund reduced its position in the online used car retailer by 8.7% in Q3 2025.
Korro Secures $85M Lifeline After Trial Setback
Cambridge biotech raises funds to advance RNA-editing programs after lead candidate misses targets
Sports
No. 25 Princeton Women Defeat Harvard 62-49
Tall, Belker, and Chea lead the Tigers to victory over the Crimson.
No. 8 Michigan rolls past No. 14 Maryland in women's basketball
Wolverines move into sole possession of second place in Big Ten standings
Skidmore Lacrosse Edges MIT in Thriller
Senior Caleb Lawson scores late go-ahead goal to lift Thoroughbreds to 14-11 road win
Health
New Cancer Therapies Target Epigenetic Switch
Researchers discover a key domain in the PRC2 protein complex that could be a target for new cancer treatments.
Experts Refute Claims of ADHD Overdiagnosis
Researchers say unmet need for assessment and treatment remains a pressing concern.
Insilico and TaiGen Achieve Milestone in CKD Anemia Collaboration
AI-driven drug candidate ISM4808 completes first-in-human dosing in Phase I trial
